SARTORIUS
Updates & Highlights
Sartorius Stedim Biotech stock (FR0013154002): earnings setback keeps investors cautious
Sartorius Stedim Biotech stock (FR0013154002): earnings setback keeps investors cautious
AD HOC NEWS · about 15 hours ago
Sartorius Kept at Sell as Mwb Notes 'More Visible' Pharma Capex Risk
Sartorius Kept at Sell as Mwb Notes 'More Visible' Pharma Capex Risk
marketscreener.com · 2 days ago
Sartorius Launches Cubis III Lab Balance with Native LIMS Connectivity and On-Instrument Compliance
Sartorius Launches Cubis III Lab Balance with Native LIMS Connectivity and On-Instrument Compliance
Lab Manager · 3 days ago
Recent Openings
View all 1 jobsCulture & Mission
Benefits & Perks
Equity/Stock Options
Ownership in the company
Health Insurance
Medical, dental & vision
Remote Work
Work from anywhere flexibility
Learning Budget
Professional development
Generous PTO
Paid time off
401(k) Match
Retirement savings
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at Sartorius?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company →News & Press
20 recentSartorius Stedim Biotech stock (FR0013154002): earnings setback keeps investors cautious
Sartorius Stedim Biotech stock (FR0013154002): earnings setback keeps investors cautious
AD HOC NEWS · about 15 hours ago
Sartorius Kept at Sell as Mwb Notes 'More Visible' Pharma Capex Risk
Sartorius Kept at Sell as Mwb Notes 'More Visible' Pharma Capex Risk
marketscreener.com · 2 days ago
Sartorius Launches Cubis III Lab Balance with Native LIMS Connectivity and On-Instrument Compliance
Sartorius Launches Cubis III Lab Balance with Native LIMS Connectivity and On-Instrument Compliance
Lab Manager · 3 days ago
Joshua Sartorius
Joshua Sartorius
Transfermarkt · 4 days ago
Sartorius Introduces Cubis® III Laboratory Balance Platform for Connected and Compliant Weighing
Sartorius Introduces Cubis® III Laboratory Balance Platform for Connected and Compliant Weighing
Laboratory Talk · 4 days ago
Sartorius AG out of favor, as mwb research maintains Sell rating
Sartorius AG out of favor, as mwb research maintains Sell rating
marketscreener.com · 5 days ago
Sartorius launches Cubis III balances with built-in compliance and connectivity
Sartorius launches Cubis III balances with built-in compliance and connectivity
Drug Discovery News · 7 days ago
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
TradingView · 9 days ago
Assessing Sartorius (XTRA:SRT3) Valuation After €140 Million Freiburg Expansion In Cell And Gene Therapy
Assessing Sartorius (XTRA:SRT3) Valuation After €140 Million Freiburg Expansion In Cell And Gene Therapy
simplywall.st · 10 days ago
Bio-Rad Is a Strategic Investor in Sartorius, With Around $5B Stake -- WSJ
Bio-Rad Is a Strategic Investor in Sartorius, With Around $5B Stake -- WSJ
Moomoo · 12 days ago
AlphaValue/Baader Europe Downgrades Sartorius Stedim Biotech to Add
AlphaValue/Baader Europe Downgrades Sartorius Stedim Biotech to Add
Moomoo · 15 days ago
AlphaValue/Baader Europe Downgrades Sartorius Stedim Biotech to Add
AlphaValue/Baader Europe Downgrades Sartorius Stedim Biotech to Add
marketscreener.com · 15 days ago
Sartorius AG Price Target, Estimates Down at AlphaValue/Baader Europe Post-FY26 Guidance
Sartorius AG Price Target, Estimates Down at AlphaValue/Baader Europe Post-FY26 Guidance
Moomoo · 15 days ago
How Investors May Respond To Bio-Rad Laboratories (BIO) Facing Elliott’s Activist Push Over Sartorius Stake
How Investors May Respond To Bio-Rad Laboratories (BIO) Facing Elliott’s Activist Push Over Sartorius Stake
simplywall.st · 15 days ago
Is Elliott’s Sartorius Push Altering The Investment Case For Bio-Rad Laboratories (BIO)?
Is Elliott’s Sartorius Push Altering The Investment Case For Bio-Rad Laboratories (BIO)?
Yahoo Finance · 16 days ago
Sartorius Stedim’s Recovery Looks Slower, Not Broken
Sartorius Stedim’s Recovery Looks Slower, Not Broken
Finimize · 16 days ago
AlphaValue/Baader Europe Cuts Forecasts, Price Target for Sartorius Stedim Biotech on FY26 Outlook
AlphaValue/Baader Europe Cuts Forecasts, Price Target for Sartorius Stedim Biotech on FY26 Outlook
marketscreener.com · 16 days ago
Sartorius Stedim Biotech Shares Mark a 6th Consecutive Session of Gains Targeting €188
Sartorius Stedim Biotech Shares Mark a 6th Consecutive Session of Gains Targeting €188
Idéal Investisseur · 19 days ago
Sartorius Stedim Biotech: Anchoring to the new guidance range
Sartorius Stedim Biotech: Anchoring to the new guidance range
marketscreener.com · 19 days ago
Sartorius Opens New Competence Center in Freiburg, Germany
Sartorius Opens New Competence Center in Freiburg, Germany
Contract Pharma · 20 days ago